Pacific Biosciences of California, Inc.
PACB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001299130
In the last 90 days, Pacific Biosciences of California, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $320.8M in total; superinvestors ARK Invest and HHLR Advisors (Hillhouse) hold it.
13F holders, Q4 2022
Institutional positions in Pacific Biosciences of California, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 237
- +15 vs. Q3 2022
- Shares held
- 224.9M
- +13.3M (+6.3%) vs. Q3 2022
- Total value
- $1.84B
- +$610.4M (+49.7%) vs. Q3 2022
- New holders
- 44
- 65 more added
- Sold out
- 29
- 77 more reduced
5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PACB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 223 | $320.8M |
| Q1 2026 | 231 | $248.5M |
| Q4 2025 | 216 | $373.5M |
| Q3 2025 | 208 | $237.8M |
| Q2 2025 | 207 | $245.8M |
| Q1 2025 | 225 | $265.6M |
| Q4 2024 | 227 | $475.1M |
| Q3 2024 | 226 | $394.3M |
| Q2 2024 | 229 | $331.9M |
| Q1 2024 | 268 | $1.01B |
| Q4 2023 | 274 | $2.76B |
| Q3 2023 | 275 | $2.20B |
| Q2 2023 | 272 | $3.37B |
| Q1 2023 | 260 | $2.93B |
| Q4 2022 | 237 | $1.84B |
| Q3 2022 | 227 | $1.23B |
| Q2 2022 | 230 | $1.03B |
| Q1 2022 | 250 | $2.03B |
| Q4 2021 | 256 | $4.20B |
| Q3 2021 | 246 | $4.83B |
| Q2 2021 | 261 | $6.04B |
| Q1 2021 | 263 | $5.47B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Pacific Biosciences of California, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 705,107 | $5.77M | 0.00% | −167,530−19.2% | Reduced |
| JPMorgan Chase & Co | 816,421 | $6.68M | 0.00% | +98,497+13.7% | Added |
| Ardsley Advisory Partners LP | 905,000 | $7.40M | 1.87% | +905,000 | New |
| Bank of New York Mellon Corp | 964,042 | $7.89M | 0.00% | +1,652+0.2% | Added |
| Senator Investment Group LP | 1,000,000 | $8.18M | 0.74% | +1,000,000 | New |
| Baker Bros. Advisors LP | 1,127,782 | $9.23M | 0.06% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,278,348 | $10.5M | 0.00% | +1,097,913+608.5% | Added |
| Morgan Stanley | 1,280,692 | $10.5M | 0.00% | −1,294,188−50.3% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 1,361,423 | $11.1M | 0.03% | +205,809+17.8% | Added |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12.0M | 4.48% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 1,580,394 | $12.9M | 0.00% | +28,287+1.8% | Added |
| Ameriprise Financial Inc | 1,615,627 | $13.2M | 0.00% | +1,579,844+4,415.1% | Added |
| Norges Bank | 1,697,527 | $13.9M | 0.00% | 00.0% | Unchanged |
| Iron Triangle Partners LP | 1,700,000 | $13.9M | 2.49% | −1,300,000−43.3% | Reduced |
| Oracle Investment Management Inc | 2,154,807 | $17.6M | 15.33% | +761,642+54.7% | Added |
| Northern Trust Corp | 2,398,143 | $19.6M | 0.00% | −15,933−0.7% | Reduced |
| Goldman Sachs Group Inc | 2,540,161 | $20.8M | 0.01% | −1,115,284−30.5% | Reduced |
| SEI Investments Co | 2,651,587 | $21.7M | 0.05% | −841,675−24.1% | Reduced |
| Capital World Investors | 3,390,000 | $27.7M | 0.01% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,425,767 | $28.0M | 0.00% | +55,139+1.6% | Added |
| Farallon Capital Management, L.L.C. | 4,004,400 | $32.8M | 0.21% | +4,004,400 | New |
| Macquarie Group Ltd | 4,012,524 | $32.8M | 0.04% | −10,748−0.3% | Reduced |
| Geode Capital Management, LLC | 4,169,610 | $34.1M | 0.00% | +140,672+3.5% | Added |
| Lord, Abbett & Co. LLC | 4,212,135 | $34.5M | 0.12% | +4,212,135 | New |
| Citadel Advisors LLC | 4,576,660 | $37.4M | 0.04% | −358,452−7.3% | Reduced |
| State Street Corp | 5,227,496 | $42.8M | 0.00% | +176,143+3.5% | Added |
| Point72 Asset Management, L.P. | 5,331,995 | $43.6M | 0.16% | +2,797,889+110.4% | Added |
| T. Rowe Price Investment Management, Inc. | 6,070,539 | $49.7M | 0.04% | −1,502,019−19.8% | Reduced |
| Capital International Investors | 6,099,681 | $49.9M | 0.01% | −2,349,477−27.8% | Reduced |
| Bellevue Group AG | 6,478,925 | $53.0M | 0.70% | +1,039,374+19.1% | Added |
| Nikko Asset Management Americas, Inc. | 14,166,193 | $115.7M | 1.67% | −225,769−1.6% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 14,166,193 | $115.9M | 0.09% | −225,769−1.6% | Reduced |
| Jackson Square Partners, LLC | 15,005,177 | $122.7M | 3.27% | −5,252,922−25.9% | Reduced |
| Madrone Advisors, LLC | 16,415,933 | $134.3M | 25.90% | +16,415,933 | New |
| BlackRock Inc. | 18,535,380 | $151.6M | 0.00% | +626,824+3.5% | Added |
| Vanguard Group Inc | 20,279,035 | $165.9M | 0.00% | +616,969+3.1% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 25,691,681 | $210.2M | 1.82% | −3,000,813−10.5% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,021,000−100.0% | Sold out |
| 12 West Capital Management LP | 0 | $0 | 0.00% | −1,925,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −453,524−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −391,993−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −389,909−100.0% | Sold out |
| Shelton Capital Management | 0 | $0 | 0.00% | −282,100−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −151,070−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −88,851−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −83,468−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −71,191−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −48,405−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −47,806−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −31,526−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −27,526−100.0% | Sold out |
| Bradley Foster & Sargent Inc | 0 | $0 | 0.00% | −21,658−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −19,808−100.0% | Sold out |
| Arete Wealth Advisors, LLC | 0 | $0 | 0.00% | −15,042−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,283−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,908−100.0% | Sold out |
| Difesa Capital Management, LP | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Inspire Advisors, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −84,400−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −5,140−100.0% | Sold out |
| Hudock, Inc. | 0 | $0 | 0.00% | −4,063−100.0% | Sold out |
| Greenwich Wealth Management LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Castle Wealth Management LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Maryland Capital Advisors Inc. | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Data Collective II GP, LLC | – | – | – | – | Not filed |
| Jefferies Group LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Covington Capital Management | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |